From molecular biology to nanotechnology and nanomedicine

BioSystems

Volumn 65, Issue 2-3, 2002, Pages 123-138

  Bogunia Kubik, Katarzyna ^a,b   Sugisaka, Masanori ^a  

^a OITA UNIVERSITY   (Japan)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Artificial cells modeling; DNA analyses; DNA computation; Nanomedicine; Nanoparticles

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; NANOPARTICLE; NUCLEIC ACID;

DNA;

CAPILLARY ELECTROPHORESIS; COMPUTER PROGRAM; DNA DETERMINATION; DNA SEQUENCE; DRUG DEVELOPMENT; GENE THERAPY; HYBRIDIZATION; IMMUNE SYSTEM; MATHEMATICAL MODEL; MOLECULAR BIOLOGY; NANOTECHNOLOGY; POLYMERASE CHAIN REACTION; REVIEW;

EID: 0036276182     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-2647(02)00010-2     Document Type: Article

References (114)

1. Molecular computation of solutions to combinatorial problems
2. Mathematical modeling of helper T lymphocyte/antigen-presenting cell interactions: analysis of methods for modifying antigen processing and presentation
3. Ligation errors in DNA computing
4. Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier
5. An evolutionary-game model of tumour-cell interactions: possible relevance to gene therapy
6. Building an associate memory vastly larger than the human brain
7. Polymerized micelles and their use as adjuvants in immunology
8. HLA typing in potential donors and recipients of hematopoietic stem cell transplantation
9. Ophthalmic drug delivery systems-recent advances
10. A model of the immune network with B-T cell co-operation. I. Prototypical structures and dynamics
11. Computation with biomolecules
12. Chip PCR: 2. Investigation of different PCR amplification systems in microfabricated silicon-glass chips
13. Transcient liquid cristal thermometry of microfabricated PCR vessel arrays
14. Modeling thymic selection and concominant immune responses on CD4+ T lymphocyte sub-populations
15. The complexities of DNA computation
16. Chitosan-based nanoparticles for topical genetic immunization
17. Chess games: a model for RNA based computation
18. A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma
19. Silicon microchamber for PCR amplification
20. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy
21. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A
22. Solid lipid nanoparticles (SLN/Lipopearls)-a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products
23. Molecular engineering: an approach to the development of general capabilities for molecular manipulation
24. Delivery systems for gene-based vaccines
25. On solving 3CNF-satisfiability with an in vivo algorithm
26. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability
27. Molecular nanotechnology
28. Molecular nanotechnology and its possible pharmaceutical implications
29. Liposome-entrappted ampicilin in the treatment of experimental murine listeriosis and salmonellosis
30. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
31. Molecular computation: RNA solutions to chess problems
32. The future of computers
33. Respirocytes: high performance artificial nanotechnology red blood cell
34. Construction of a genetic toggle switch in Escherichia coli
35. Myb targeted therapeutics for the treatment of human malignancies
36. Making DNA add
37. Nanotechnology in bio/clinical analysis
38. Stimulation of Drosophila embryogenesis
39. Computing with DNA by operating on plasmids
40. Chitosan a novel nasal delivery system for vaccines
41. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin
42. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
43. Mechanical manipulation of single titin molecules with laser tweezers
44. A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin A
45. Nanoparticulate systems for brain delivery of drugs
46. Nano and microparticles as controlled drug delivery devices
47. Monolithic integrated microfluid DNA amplification and capillary electrophoresis analysis system
48. Nanoparticulate systems for the delivery of antisense oligonucleotides
49. Nanotechnology promises to revolutionize the diagnosis and treatment of diseases
50. Biomaterials in drug delivery and tissue engineering: one laboratory's experience
51. Three-cell interactions in T cell-mediated suppression? A mathematical analysis of its quantitative implications
52. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma
53. Visualization of PEO-PBLA-pyrene polymeric micelles by atomic force microscopy
54. On the potential of molecular computing
55. DNA solution of hard computational problems
56. DNA computing on surfaces
57. On the potential of molecular computing
58. Characterization of oligonucleotide transport into living cells
59. A nanomechanical device based on the B-Z transition of DNA
60. Gene therapy: the first decade
61. Specific enzymatic amplificatiopn of DNA in vitro: the polymerase chain reaction
62. A miniature analytical instrument for nucleic acids based on micromachined silicon reaction chambers
63. Successful peripheral T-lymphocyte-direct gene transfer for a patient with severe combine immune deficiency caused by adenosine deaminase deficiency
64. DNA solution of the maximal clique problem
65. Scanning probe microscopy and medico-biological nanotechnology: history and prospects
66. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia. A
67. Molecular computing: does DNA compute
68. Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
69. Use of vitamin B12 conjugates to deliver protein drugs by the oral route
70. Vitamin B12 transporters
71. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells
72. Analysis of enzymatically amplified B-globin and HLADQa DNA with allele-specific oligonucleotide probes
73. Gel electrophoresis of DNA
74. Nanoparticle technology for delivery of drugs across the blood-brain barrier
75. DNA engineering and its application to nanotechnology
76. New motifs in DNA nanotechnology
77. DNA-based non-invasive vaccination onto the skin
78. Mathematical modeling of gene networks
79. Modeling transcriptional control in gene networks-methods, recent results, and future directions
80. Biodegradable polymeric nanoparticles as drug delivery devices
81. Nucleic acids molecular switches
82. Design of folic acid-conjugated nanoparticles for drug targeting
83. A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly
84. A formal model of an artificial immune system
85. Boning up on biology
86. Process control for optimal PCR performance in glass microstructures
87. Rho Chi lecture. Pharmaceutical sciences in the next millennium
88. DNA vaccines
89. Neural network model of gene expression
90. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma
91. Multiple sample PCR amplification and electrophoretic analysis on a microchip
92. Integrated cell isolation and polymerase chain reaction analysis using silicon microfilter chambers
93. Biomedical microdevices and nanotechnology
94. Functional integration of PCR amplification and capillary electrophoresis in a microfabricated DNA analysis device
95. Direct haplotyping of kilobase-size DNA using carbon nanotube probes
96. Mechanism of oligonucleotides uptake vy cells: involvement of specific receptors
97. Cytokine-modulated regulation of helper T cell populations
98. Gene expression analysis as an aid to the identification of drug targets
99. Automated and integrated system for high-throughput DNA genotyping directly from blood